Mogrify is a series a startup based in United Kingdom. 1 investor tracked.
Mogrify is a startup founded in 2016 based in the United Kingdom. Brouky records 4 investors associated with the company.
Mogrify is a UK biotechnology company developing in vivo cellular reprogramming therapies. It uses proprietary transcriptomic and epigenetic platform technologies to identify factors that convert one cell type to another for therapeutic applications in otology, ophthalmology, diabetes and other diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.